MVA-EBOV

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameMVA-EBOV
Drug Alias NameMVA-EBOV
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnti-EBOV
TargetsEBOV
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGeovax Inc
China Registration ClassN/A

Develop Information

Active CompaniesGeovax Inc
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fever, Ebola
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A